US Patent Issued to Lotus Biotech.com on March 24 for "Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy" (American, Chinese Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,691, issued on March 24, was assigned to Lotus Biotech.com LLC (Gaithersburg, Md.).

"Administration of Yunnan Baiyao or Xingnaojing in patients with moderate-to-severe traumatic brain injury and craniotomy" was invented by Guoqiang Xing (Gaithersburg, Md.) and Xiaodong Ma (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Clinically validated methods of administering Yunnan Baiyao or Xingnaojing can improve postoperative recovery and long-term clinical prognosis of patients with moderate-to-severe traumatic brain injury (TBI) and emergency craniotomy. Both medicinal methods are useful for minimizing or inhibiting the adverse impacts of seconda...